Satellite Symposium Amgen (Europe) GmbH : Optimising Bone Health: recognising and treating a wide patient spectrum – Chairs : Roland Chapurlat (France) & Richard Eastell (UK)

Welcome and Introduction – Roland Chapurlat (France) & Richard Eastell (UK)

What is the optimal long-term treatment sequence for osteoporosis patient ? – Richard Eastell (UK)

An update on osteoporotic patients with diabetes – Lorenz Hofbauer (Germany)

Clinical updates in osteogenesis imperfecta – Jorg Semler (Germany)

Building stronger bones: a new approach to fracture management in severe osteoporosis – Chair : Thierry Thomas, France 

14:45-14:50 Welcome and Introduction – Thierry Thomas, France (Chair)

14:50–15:10 Improving bone strength in women with severe osteoporosis: An opportunity to take a different approach? – John Carey, Ireland

15:10–15:45 Mechanisms and effects of therapeutic interventions on bone microstructure and strength – Roland Baron, USA

15:45–16:10 A new treatment option for women with severe osteoporosis – Bente Langdahl, Denmark 

16:10–16:15 Conclusion and closing remarks – Thierry Thomas, France (Chair)

Mini Symposium Gedeon Richter : Bone Anabolic Treatment – The past, the present and the future – Chairs : Prof. Peyman Hadji

 How to individualise treatment – an interactive case presentation – Peyman Hadji (Germany)

Mini Symposium Inozyme: Educational Symposium 1: The Natural History of ENPP1 Deficiency: A Clinical Spectrum from GACI to ARHR2

 A Natural History of ENPP1 deficiency – Frank Rutsch (Germany)

GACI & ARHR2: Lessons learnt from a clinical case – Zulf Mughal (United Kingdom)

The key role of PPi in driving diseases of ectopic mineralization – Pedro Huertas (United States)

Discussion Time

More information soon…